Dr. Andrea R Hagemann, M.D., MSCI
Claim this profileWashington University School of Medicine
Studies Endometrial Cancer
Studies Cervical Cancer
16 reported clinical trials
31 drugs studied
Area of expertise
1Endometrial Cancer
MSI-H positive
HER2 positive
dMMR positive
2Cervical Cancer
Stage IV
Stage III
Stage II
Affiliated Hospitals
Clinical Trials Andrea R Hagemann, M.D., MSCI is currently running
Zanzalintinib + Paclitaxel
for Uterine Cancer
The purpose of this study is to determine the recommended Phase 2 dose of zanzalintinib when given in combination with paclitaxel in patients with recurrent high-grade uterine cancer. Other objectives include overall safety and tolerability as well as rates of response.
Recruiting1 award Phase 15 criteria
Social Needs Support
for Cervical Cancer Screening Follow-Up
The investigators will perform a randomized controlled trial in which 72 eligible patients (low-income, uninsured, or on Medicaid) who are referred for colposcopy at Washington University School of Medicine, are enrolled and then screened for unmet social needs and distress. The participants will then be randomized 1:1 into either receive the social needs navigator program (n=36) or enhanced usual care (n=36).
Recruiting1 award N/A
More about Andrea R Hagemann, M.D., MSCI
Clinical Trial Related1 year of experience running clinical trials · Led 16 trials as a Principal Investigator · 8 Active Clinical TrialsTreatments Andrea R Hagemann, M.D., MSCI has experience with
- Paclitaxel
- Progestin
- Semaglutide
- Telemedicine Behavioral Weight Intervention
- Levonorgestrel-releasing IUD
- Telemedicine Behavioral Weight Intervention
Breakdown of trials Andrea R Hagemann, M.D., MSCI has run
Endometrial Cancer
Cervical Cancer
Ovarian Cancer
Endometrial Hyperplasia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Andrea R Hagemann, M.D., MSCI specialize in?
Andrea R Hagemann, M.D., MSCI focuses on Endometrial Cancer and Cervical Cancer. In particular, much of their work with Endometrial Cancer has involved MSI-H positive patients, or patients who are HER2 positive.
Is Andrea R Hagemann, M.D., MSCI currently recruiting for clinical trials?
Yes, Andrea R Hagemann, M.D., MSCI is currently recruiting for 8 clinical trials in Saint Louis Missouri. If you're interested in participating, you should apply.
Are there any treatments that Andrea R Hagemann, M.D., MSCI has studied deeply?
Yes, Andrea R Hagemann, M.D., MSCI has studied treatments such as Paclitaxel, Progestin, Semaglutide.
What is the best way to schedule an appointment with Andrea R Hagemann, M.D., MSCI?
Apply for one of the trials that Andrea R Hagemann, M.D., MSCI is conducting.
What is the office address of Andrea R Hagemann, M.D., MSCI?
The office of Andrea R Hagemann, M.D., MSCI is located at: Washington University School of Medicine, Saint Louis, Missouri 63110 United States. This is the address for their practice at the Washington University School of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.